Summary
The CCAAT/enhancer binding protein (C/EBP) family of transcription factors is involved in metabolism and differentiation of cells, especially in rodent liver cells and adipocytes. Their roles in vivo and in particular during pathophysiological conditions in humans are largely unknown. We have investigated the presence of C/EBPα, -β, -δ and -ζ in normal ovaries and in epithelial ovarian tumours of different stages. Immunohistochemical experiments demonstrated that C/EBPα and C/EBPβ were preferentially expressed in epithelial/tumour cells irrespective of stage or grade of the tumour. C/EBPβ was located in the nuclei of the cells, in contrast to C/EBPα, which was present only in the cytoplasm of these cells. The nuclear localization of C/EBPβ indicates an active role of this transcription factor in tumour cells, whereas the cytoplasmic distribution suggests a more passive function of C/EBPα. C/EBPδ and -ζ demonstrated a more diverse distribution with predominant localization to epithelial cells, but stromal distribution was also noted. The intracellular distribution was confined to both the nucleus and the cytoplasm for C/EBPδ and -ζ. Western blotting demonstrated that C/EBPα, -β, -δ and -ζ were present in a majority of the samples. The amount of C/EBPβ increased markedly with malignancy, i.e. with degree of dedifferentiation, while the other members of the C/EBP family displayed a more constant expression level. These results demonstrate an association between the expression of members of the C/EBP family and the formation of epithelial ovarian tumours, with C/EBPβ as a potential marker for these tumours. As C/EBPβ is known to be expressed during proliferation of cells in vitro, it may participate in the proliferative process of ovarian epithelial tumour cells in vivo and play a central role in tumour progression.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T. & Kishimoto, T. (1990). A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9: 1897–1906.
Akira, S. & Kishimoto, T. (1992). IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127: 25–50.
Altman, D. G. (1991). Practical Statistics for Medical Research, Chapman and Hall: London
Åman, P., Ron, D., Mandahl, N., Fioretos, T., Heim, S., Arheden, K., Willén, H., Rydholm, A. & Mitelman, F. (1992). Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas With t(12;16)(q13;p11). Gene Chrom Cancer 5: 278–285.
Batchvarova, N., Wang, X-Z & Ron, D. (1995). Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd 153). EMBO J 14: 4654–4661.
Cao, Z., Umek, R. M. & McKnight, S. L. (1991). Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5: 1538–1552.
Chandrasekaran, C. & Gordon, J. I. (1993). Cell lineage-specific and differentiation-dependent patterns of CCAAT/enhancer binding protein α expression in the gut epithelium of normal and transgenic mice. Proc Natl Acad Sci USA 90: 8871–8875.
Chen, P. L., Riley, D. J., Chen-Kiang, S. & Lee, W. H. (1996). Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Natl Acad Sci USA 93: 465–469.
Descombes, P. & Schibler, U. (1991). A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67: 569–579.
Dodson, M. K., Cliby, W. A., Xu, H. J., DeLacey, K. A., Hu, S. X., Keeney, G. L., Li, J., Podratz, K. C., Jenkins, R. B. & Benedict, W. F. (1994). Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res 54: 610–603.
Ghosh, S. & Baltimore, D. (1990). Activation in vitro of NF Kappa B by phosphorylation of its inhibitor I kappa B. Nature 344: 678–682.
Hamilton, T. C. (1992). Ovarian Cancer, part 1: Biology. In Curr Prob Cancer 16: 1–57.
Ivarsson, K. U., Runesson, E. B., Haeger, M., Sundfeldt, K., Hedin, L. F., Janson, P. O. & Brännström, M. (1999). The chemotactic cytokine interleukin-8 (IL-8) a cyst fluid marker for malignant human epithelial ovarian cancer. Gynecol Oncol, (in press)
Li, F., Rosenberg, E., Smith, C. I., Notarfrancesco, K., Reisher, S. R., Shuman, H. & Feinstein, S. I. (1995). Correlation of expression of transcription factor C/EBP-α and surfactant protein genes in lung cells. Am J Physiol 269: L241–L247.
Lin, F-T, MacDougald, O. A., Diehl, A. M. & Lane, M. D. (1993). A 30-kDa alternative translation product of the CCAAT/enhancer binding protein α message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci USA 90: 9606–9610.
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsashima, K., Kishimoto, T. & Akira, S. (1993). Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90: 10193–10197.
McKnight, S. L. (1991). C/EBP: A transcription factor that promotes terminal cell differentiation in a wide spectrum of tissues. In Origins of Human Cancer: a Comprehensive Review, Brugge J, Curran T, Harlow E, McCormick F (eds) pp. 345–352, Cold Spring Harbor Laboratory Press: Cold Spring Harbor
Metz, E. & Ziff, E. (1991). cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to translocate to the nucleus and induce c-fos transcription. Genes Dev 5: 1754–1766.
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D. & Balkwill, F. R. (1993). Tumour necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 91: 2194–2206.
Park, E. A., Gurney, A. L., Nizielski, S. E., Hakimi, P., Cao, Z., Moorman, A. & Hanson, R. W. (1993). Relative roles of CCAAT/enhancer-binding protein beta and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP). J Biol Chem 268: 613–609.
Piontkewitz, Y., Enerbäck, S. & Hedin, L. (1993). Expression and hormonal regulation of the CCAAT enhancer binding protein-α during differentiation of rat ovarian follicles. Endocrinology 133: 2327–2333.
Poli, V., Mancini, F. P. & Cortese, R. (1990). IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63: 643–653.
Rana, B., Xie, Y., Mischoulon, D., Bucher, N. L. & Farmer, S. R. (1995). The DNA binding activity of C/EBP transcription factor is regulated in the G1 phase of the hepatocyte cell cycle. J Biol Chem 270: 18123–18132.
Raught, B., Liao, WS-L & Rosen, J. M. (1995). Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence β-casein gene expression. Mol Endocrinology 9: 1223–1232.
Ron, D. & Habener, J. F. (1992). CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439–453.
Samuelsson, L., Strömberg, K., Vikman, K., Bjursell, G. & Enerbäck, S. (1991). The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development. EMBO J 10: 3787–3793.
Scott, L. M., Civin, C. I., Rorth, P. & Friedman, A. D. (1992). A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80: 1725–1735.
Silverberg, E. (1984). Cancer Statistics. CA Cancer J Clin 34: 7–23.
Takasaki, Y., Deng, J. S. & Tan, E. M. (1981). A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 154: 1899–1909.
Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N. & Kishimoto, T. (1995). Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumour cytotoxicity by macrophages. Cell 80: 353–361.
Timchenko, N. A., Wilde, M., Nakanishi, M., Smith, J. R. & Darlington, G. J. (1996). CCAAT/enhancer-binding protein alpha (C/EBP-α) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 10: 804–815.
Umek, R. M., Friedman, A. D. & McKnight, S. L. (1991). CCAAT-enhancer binding protein: a component of differentiation switch. Science 251: 288–292.
Vinson, C. R., Hai, T. & Boyd, S. M. (1993). Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design. Genes Dev 7: 1047–1058.
Watkins, P. J., Condresay, J. P., Huber, B. E., Jacobs, S. J. & Adams, D. J. (1996). Impaired proliferation and tumorigenicity induced by CCAAT/ enhancer binding protein. Cancer Res 56: 1063–1067.
Watson, J. M., Berek, J. S. & Martínez-Maza, O. (1993). Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides. Gynecol Oncol 49: 8–15.
Wegner, M., Cao, Z. & Rosenfeld, M. G. (1992). Calcium-regulated phosphorylation within the leucin zipper of C/EBP. Science 256: 370–373.
Wu, S., Boyer, C. M., Whitaker, R. S., Berchuck, A., Wiener, J. R., Weinberg, J. B. & Bast, R. C. (1993). Tumour necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumour cell proliferation and tumour necrosis factor alpha expression. Cancer Res 53: 1939–1944.
Xu, L-X, Sui, Y-F, Wang, W-L, Liu, Y-F & Gu, J-R (1994). Immunohistochemical demonstration of CCAAT/Enhancer Binding Protein (C/EBP) in human liver tissues of various origin. Chin Med J 107: 596–599.
Yin, M., Yang, S. Q., Lin, H. Z., Lane, M. D., Chatterjee, S. & Diehl, A. M. (1996). Tumour Necrosis Factor α promotes nuclear localization of cytokine-inducible CCAAT/Enhancer Binding Protein isoform in hepatocytes. J Biol Chem 271: 17974–17978.
Zahnow, C. A., Younes, P., Laucirica, R. & Rosen, J. M. (1997). Overexpression of C/EBP–LIP, a naturally occurring, dominant–negative transcription factor, in human breast cancer. JNCI 89: 1887–1891.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Sundfeldt, K., Ivarsson, K., Carlsson, M. et al. The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPβ during epithelial tumour progression. Br J Cancer 79, 1240–1248 (1999). https://doi.org/10.1038/sj.bjc.6690199
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690199
Keywords
This article is cited by
-
Metformin inhibits human non-small cell lung cancer by regulating AMPK–CEBPB–PDL1 signaling pathway
Cancer Immunology, Immunotherapy (2022)
-
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia
Oncogene (2021)
-
C/EBPβ-LIP induces cancer-type metabolic reprogramming by regulating the let-7/LIN28B circuit in mice
Communications Biology (2019)
-
C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event
Cell Death & Disease (2018)
-
A computational framework for complex disease stratification from multiple large-scale datasets
BMC Systems Biology (2018)